F. Liu, M. Korc, Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells, Mol Cancer Ther 11 (2012) 2138-2148.
 N.A. Schultz, C. Dehlendorff, B.V. Jensen, J.K. Bjerregaard, K.R. Nielsen, S.E. Bojesen, D. Calatayud, S.E. Nielsen, M. Yilmaz, N.H. Hollander, K.K. Andersen, J.S. Johansen, MicroRNA biomarkers in whole blood for detection of pancreatic cancer, Jama 311 (2014) 392-404.
 A. Pandita, S. Manvati, S.K. Singh, S. Vaishnavi, R.N. Bamezai, Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines, Chem Biol Interact 233 (2015) 56-64.
 Y. Shao, M. Ye, Q. Li, W. Sun, G. Ye, X. Zhang, Y. Yang, B. Xiao, J. Guo, LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer, Oncotarget (2016).
 X. Zhou, H. Chen, L. Zhu, B. Hao, W. Zhang, J. Hua, H. Gu, W. Jin, G. Zhang, Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c, Oncotarget 7 (2016) 82770-82782.
 H. Xia, Q. Chen, Y. Chen, X. Ge, W. Leng, Q. Tang, M. Ren, L. Chen, D. Yuan, Y. Zhang, M. Liu, Q. Gong, F. Bi, The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis, Oncotarget 7 (2016) 56209-56218.
 Y. Cui, F. Zhang, C. Zhu, L. Geng, T. Tian, H. Liu, Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/beta-catenin signaling pathway, Oncotarget 8 (2017) 17785-17794.
 H. Cai, J. Yao, Y. An, X. Chen, W. Chen, D. Wu, B. Luo, Y. Yang, Y. Jiang, D. Sun, X. He, LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer, Oncotarget (2017).
 H.W. Xie, Q.Q. Wu, B. Zhu, F.J. Chen, L. Ji, S.Q. Li, C.M. Wang, Y.S. Tong, L. Tuo, M. Wu, Z.H. Liu, J. Lv, W.H. Shi, X.F. Cao, Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis, Tumour Biol 35 (2014) 7743-7754.
 V. Mouraviev, B. Lee, V. Patel, D. Albala, T.E. Johansen, A. Partin, A. Ross, R.J. Perera, Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer, Prostate Cancer Prostatic Dis 19 (2016) 14-20.
 F. Shen, W.S. Cai, Z. Feng, J.W. Chen, J.H. Feng, Q.C. Liu, Y.P. Fang, K.P. Li, H.Q. Xiao, J. Cao, B. Xu, Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition, Oncotarget (2016).
 J. Mazar, W. Zhao, A.M. Khalil, B. Lee, J. Shelley, S.S. Govindarajan, F. Yamamoto, M. Ratnam, M.N. Aftab, S. Collins, B.N. Finck, X. Han, J.S. Mattick, M.E. Dinger, R.J. Perera, The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells, Oncotarget 5 (2014) 8959-8969.
 X.L. Zhao, Z.H. Zhao, W.C. Xu, J.Q. Hou, X.Y. Du, Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer, Int J Clin Exp Pathol 8 (2015) 1954-1960.
 Y. Zhou, D.L. Wang, Q. Pang, Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma, Eur Rev Med Pharmacol Sci 20 (2016) 3035-3039.
 D. Khaitan, M.E. Dinger, J. Mazar, J. Crawford, M.A. Smith, J.S. Mattick, R.J. Perera, The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion, Cancer Res 71 (2011) 3852-3862.
 D. Cao, Q. Ding, W. Yu, M. Gao, Y. Wang, Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial-mesenchymal transition, Onco Targets Ther 9 (2016) 5417-5425.
 C.Y. Zhang, R.K. Li, Y. Qi, X.N. Li, Y. Yang, D.L. Liu, J. Zhao, D.Y. Zhu, K. Wu, X.D. Zhou, S. Zhao, Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition, Cell Biol Toxicol 32 (2016) 391-401.
 M. Sun, X.H. Liu, K.H. Lu, F.Q. Nie, R. Xia, R. Kong, J.S. Yang, T.P. Xu, Y.W. Liu, Y.F. Zou, B.B. Lu, R. Yin, E.B. Zhang, L. Xu, W. De, Z.X. Wang, EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition, Cell Death Dis 5 (2014) e1298.
 C.C. Liang, A.Y. Park, J.L. Guan, In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro, Nat Protoc 2 (2007) 329-333.
 C. Yu, M. Wang, Z. Li, J. Xiao, F. Peng, X. Guo, Y. Deng, J. Jiang, C. Sun, MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1, Cell Oncol (Dordr) 38 (2015) 173-181.
 S. Tian, X. Guo, C. Yu, C. Sun, J. Jiang, miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1, Oncotarget (2016).
 Y. Zhang, C. Lin, G. Liao, S. Liu, J. Ding, F. Tang, Z. Wang, X. Liang, B. Li, Y. Wei, Q. Huang, X. Li, B. Tang, MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2, Oncotarget 6 (2015) 32586-32601.
 P. Wang, Z. Li, H. Liu, D. Zhou, A. Fu, E. Zhang, MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2, Biochem Biophys Res Commun 479 (2016) 91-96.
 F. Zheng, Y.J. Liao, M.Y. Cai, Y.H. Liu, T.H. Liu, S.P. Chen, X.W. Bian, X.Y. Guan, M.C. Lin, Y.X. Zeng, H.F. Kung, D. Xie, The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2, Gut 61 (2012) 278-289.
 D. Liu, Y. Li, G. Luo, X. Xiao, D. Tao, X. Wu, M. Wang, C. Huang, L. Wang, F. Zeng, G. Jiang, LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2, Cancer Lett 388 (2016) 281-291.
 M. Zhou, X.Y. Zhang, X. Yu, Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma, Biomed Pharmacother 85 (2017) 348-354.
 P. Chen, D. Wan, D. Zheng, Q. Zheng, F. Wu, Q. Zhi, Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer, Biomed Pharmacother 83 (2016) 1220-1226.
 W. Peng, A. Jiang, Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer, Biomed Pharmacother 83 (2016) 712-717.
 H.X. Zhan, Y. Wang, C. Li, J.W. Xu, B. Zhou, J.K. Zhu, H.F. Han, L. Wang, Y.S. Wang, S.Y. Hu, LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway, Cancer Lett 374 (2016) 261-271.
 M. Xie, F.Q. Nie, M. Sun, R. Xia, Y.W. Liu, P. Zhou, W. De, X.H. Liu, Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition, J Transl Med 13 (2015) 250.
 J. Xue-Liang, W. Ming-Dong, Z. Ya-Bi, W. Wang-Yue, Upregulated long noncoding RNA SPRY4-IT1 contributes to increased cell viability by activating zinc finger 703 expression in esophageal squamous cell carcinoma, Indian J Cancer 52 Suppl 3 (2015) E164-167.
 Y. Mei, J. Si, Y. Wang, Z. Huang, H. Zhu, S. Feng, X. Wu, L. Wu, Long noncoding RNA GAS5 suppresses tumorigenesis by inhibiting miR-23a 5 expression in non-small cell lung cancer, Oncol Res (2017).
 X.B. Zhao, G.S. Ren, LncRNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation by Inhibiting MicroRNA-9 in MCF-7 Cells, J Breast Cancer 19 (2016) 349-357.